The androgen receptor is a therapeutic target in desmoplastic small round cell sarcoma
Authors:
- Salah-Eddine Lamhamedi-CherradiSLSalah-Eddine Lamhamedi-Cherradi
- Mayinuer MaitituohetiMMMayinuer Maitituoheti
- Brian A. MenegazBMBrian A. Menegaz
- Sandhya KrishnanSKSandhya Krishnan
- Chia-Chin WuCWChia-Chin Wu
- Hannah C. BeirdHBHannah C. Beird
- Robert W. PorterRPRobert W. Porter
- Davis R. IngramDIDavis R. Ingram
- Sana MohiuddinSMSana Mohiuddin
Open Access
- 1 June 2022
- journal article
- research article
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-16
Abstract
Desmoplastic small round cell tumor (DSRCT) is an aggressive, usually incurable sarcoma subtype that predominantly occurs in post-pubertal young males. Recent evidence suggests that the androgen receptor (AR) can promote tumor progression in DSRCTs. However, the mechanism of AR-induced oncogenic stimulation remains undetermined. Herein, we demonstrate that enzalutamide and AR-directed antisense oligonucleotides (AR-ASO) block 5α-dihydrotestosterone (DHT)-induced DSRCT cell proliferation and reduce xenograft tumor burden. Gene expression analysis and chromatin immunoprecipitation sequencing (ChIP-seq) were performed to elucidate how AR signaling regulates cellular epigenetic programs. Remarkably, ChIP-seq revealed novel DSRCT-specific AR DNA binding sites adjacent to key oncogenic regulators, including WT1 (the C-terminal partner of the pathognomonic fusion protein) and FOXF1. Additionally, AR occupied enhancer sites that regulate the Wnt pathway, neural differentiation, and embryonic organ development, implicating AR in dysfunctional cell lineage commitment. Our findings have direct clinical implications given the widespread availability of FDA-approved androgen-targeted agents used for prostate cancer.Keywords
All Related Versions
Funding Information
- Foundation for the National Institutes of Health (CA016672)
This publication has 82 references indexed in Scilit:
- STAR: ultrafast universal RNA-seq alignerBioinformatics, 2012
- clusterProfiler: an R Package for Comparing Biological Themes Among Gene ClustersOMICS: A Journal of Integrative Biology, 2012
- Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancerThe EMBO Journal, 2011
- Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate CancerCancer Cell, 2011
- Integrative genomics viewerNature Biotechnology, 2011
- MapSplice: Accurate mapping of RNA-seq reads for splice junction discoveryNucleic Acids Research, 2010
- Integrative Genomic Profiling of Human Prostate CancerCancer Cell, 2010
- Simple Combinations of Lineage-Determining Transcription Factors Prime cis-Regulatory Elements Required for Macrophage and B Cell IdentitiesMolecular Cell, 2010
- edgeR: a Bioconductor package for differential expression analysis of digital gene expression dataBioinformatics, 2009
- PGC-1α-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetesNature Genetics, 2003